Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial

Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease

(2018) Eleonora Scorletti et al.   Contemporary Clinical Trials

OUP accepted manuscript

(2018)   NUTRITION REVIEWS

Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats

(2018) Yinji Liang et al.   Probiotics and Antimicrobial Proteins

Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents

(2017) Fatemeh Famouri et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease

(2015) A. Wieland et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol

(2015) Jennifer E. Lambert et al.   BMC GASTROENTEROLOGY

Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease

(2015) Giovanni Tarantino et al.   Future Microbiology

Urinary 1H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment

(2015) A Miccheli et al.   INTERNATIONAL JOURNAL OF OBESITY

Dairy Consumption Lowers Systemic Inflammation and Liver Enzymes in Typically Low-Dairy Consumers with Clinical Characteristics of Metabolic Syndrome

(2015) Christine E. Dugan et al.   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis

(2014) A. Alisi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease

(2014) S. Nabavi et al.   JOURNAL OF DAIRY SCIENCE

Oat Prevents Obesity and Abdominal Fat Distribution, and Improves Liver Function in Humans

(2013) Hong-Chou Chang et al.   PLANT FOODS FOR HUMAN NUTRITION

Effects of High Performance Inulin Supplementation on Glycemic Control and Antioxidant Status in Women with Type 2 Diabetes

(2013) Bahram Pourghassem Gargari et al.   Diabetes & Metabolism Journal

Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease

(2012) D. Compare et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes

(2011) Eduardo Esteve et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis

(2011) Michele Malaguarnera et al.   DIGESTIVE DISEASES AND SCIENCES

A Novel Antiinflammatory Role for the Short-Chain Fatty Acids in Human Labor

(2011) Chiara Voltolini et al.   ENDOCRINOLOGY

The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance

(2011) Jill A. Parnell et al.   LIVER INTERNATIONAL

Impact of a synbiotic food on the gut microbial ecology and metabolic profiles

(2010) Beatrice Vitali et al.   BMC MICROBIOLOGY

Yacon syrup: Beneficial effects on obesity and insulin resistance in humans

(2009) Susana Genta et al.   CLINICAL NUTRITION